These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9751526

  • 21. Cloning of the human sodium lodide symporter.
    Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM.
    Biochem Biophys Res Commun; 1996 Sep 13; 226(2):339-45. PubMed ID: 8806637
    [Abstract] [Full Text] [Related]

  • 22. Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50.
    Venkataraman GM, Yatin M, Ain KB.
    Thyroid; 1998 Jan 13; 8(1):63-9. PubMed ID: 9492156
    [Abstract] [Full Text] [Related]

  • 23. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
    Seissler J, Wagner S, Schott M, Lettmann M, Feldkamp J, Scherbaum WA, Morgenthaler NG.
    J Clin Endocrinol Metab; 2000 Dec 13; 85(12):4630-4. PubMed ID: 11134119
    [Abstract] [Full Text] [Related]

  • 24. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
    Tonacchera M, Agretti P, Ceccarini G, Lenza R, Refetoff S, Santini F, Pinchera A, Chiovato L, Vitti P.
    Eur J Endocrinol; 2001 Jun 13; 144(6):611-8. PubMed ID: 11375795
    [Abstract] [Full Text] [Related]

  • 25. Human sodium iodide symporter (hNIS) in fibroadenoma breast--a immunohistochemical study.
    Rai R, Shrivastava A, Tandon A, Godbole MM, Kumar S, Das V, Dwivedi V, Pal L.
    Indian J Exp Biol; 2011 Feb 13; 49(2):113-7. PubMed ID: 21428212
    [Abstract] [Full Text] [Related]

  • 26. hNIS protein in thyroid: the iodine supply influences its expression and localization.
    Scipioni A, Ferretti E, Soda G, Tosi E, Bruno R, Costante G, Meringolo D, Arturi F, Durante C, Amorosi A, Foschini MP, Nardi F, Russo D, Filetti S.
    Thyroid; 2007 Jul 13; 17(7):613-8. PubMed ID: 17696829
    [Abstract] [Full Text] [Related]

  • 27. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Romijn JA, van der Heide D.
    Exp Clin Endocrinol Diabetes; 2001 Jul 13; 109(1):52-5. PubMed ID: 11573141
    [Abstract] [Full Text] [Related]

  • 28. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
    Pohlenz J, Duprez L, Weiss RE, Vassart G, Refetoff S, Costagliola S.
    J Clin Endocrinol Metab; 2000 Jul 13; 85(7):2366-9. PubMed ID: 10902780
    [Abstract] [Full Text] [Related]

  • 29. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter.
    Ryu KY, Senokozlieff ME, Smanik PA, Wong MG, Siperstein AE, Duh QY, Clark OH, Mazzaferri EL, Jhiang SM.
    Thyroid; 1999 Apr 13; 9(4):405-9. PubMed ID: 10319949
    [Abstract] [Full Text] [Related]

  • 30. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Stokkel M, van der Heide D, Romijn JA.
    J Clin Endocrinol Metab; 2002 Mar 13; 87(3):1247-53. PubMed ID: 11889195
    [Abstract] [Full Text] [Related]

  • 31. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
    Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muramatsu A, Onaya T.
    J Clin Invest; 1998 Apr 01; 101(7):1296-300. PubMed ID: 9525971
    [Abstract] [Full Text] [Related]

  • 32. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
    Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, Porra V, Berger-Dutrieux N, Decaussin M, Peix JL, Perrin A, Bournaud C, Orgiazzi J, Borson-Chazot F, Franc B, Rousset B.
    Am J Pathol; 2004 Jul 01; 165(1):25-34. PubMed ID: 15215159
    [Abstract] [Full Text] [Related]

  • 33. Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue.
    Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T.
    J Clin Endocrinol Metab; 1997 Oct 01; 82(10):3331-6. PubMed ID: 9329364
    [Abstract] [Full Text] [Related]

  • 34. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues.
    Liou MJ, Lin JD, Chan EC, Liu FH, Chao TC, Weng HF.
    Cancer Lett; 2000 Nov 10; 160(1):75-80. PubMed ID: 11098087
    [Abstract] [Full Text] [Related]

  • 35. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C, Winzer R, Meissner-Weigl J, Köhrle J.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):832-8. PubMed ID: 9398654
    [Abstract] [Full Text] [Related]

  • 36. Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter.
    Lin X, Fischer AH, Ryu KY, Cho JY, Sferra TJ, Kloos RT, Mazzaferri EL, Jhiang SM.
    J Clin Endocrinol Metab; 2004 May 26; 89(5):2344-50. PubMed ID: 15126562
    [Abstract] [Full Text] [Related]

  • 37. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2005 Aug 26; 90(8):4457-64. PubMed ID: 15941870
    [Abstract] [Full Text] [Related]

  • 38. Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues.
    Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, Bidart JM.
    Eur J Endocrinol; 2001 Mar 26; 144(3):297-302. PubMed ID: 11248751
    [Abstract] [Full Text] [Related]

  • 39. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter.
    Zhang Z, Liu YY, Jhiang SM.
    J Clin Endocrinol Metab; 2005 Nov 26; 90(11):6131-40. PubMed ID: 16105966
    [Abstract] [Full Text] [Related]

  • 40. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
    Schmutzler C, Köhrle J.
    Exp Clin Endocrinol Diabetes; 1998 Nov 26; 106 Suppl 3():S1-10. PubMed ID: 9865544
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.